Clinical Trials Directory

Trials / Completed

CompletedNCT06960148

Dentinal Hypersensitivity Reduction Efficacy Study

Clinical Investigation of the Dentinal Hypersensitivity Reduction Efficacy of CSPR Toothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste Immediately Following Direct Topical Application of the Product and After Subsequent Brushing With the Product for Eight Weeks.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
95 (actual)
Sponsor
Colgate Palmolive · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief

Detailed description

The objective of this study is to assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief (tactile and air blast) at instant, 3 days, 4 weeks and 8 weeks in comparison to Colgate Cavity Protection Toothpaste over an eight-week period.

Conditions

Interventions

TypeNameDescription
DRUGCSPR Toothpastea commercially available 8% arginine toothpaste
DRUGColgate Dental Cream Toothpastea commercially available fluoride toothpaste

Timeline

Start date
2025-03-04
Primary completion
2025-05-13
Completion
2025-05-13
First posted
2025-05-07
Last updated
2026-03-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06960148. Inclusion in this directory is not an endorsement.